Latest news
Neurocrine Biosciences, Inc. (NB3.F) Analyst insights, Price targets and Recommendations - Yahoo Finance AustraliaYahoo Finance Australia · Sat, 08 Aug 2026 22:44:58 GMTNeurocrine Biosciences, Inc. (NBIX) Stock Forecasts - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 01:53:30 GMTNeurocrine Biosciences (NBIX) Is Down 5.1% After Q2 Earnings Beat And Higher INGREZZA Guidance – What's Changed - Yahoo FinanceYahoo Finance · Sat, 01 Aug 2026 07:00:00 GMTNeurocrine Biosciences (NBIX) Appoints Four Senior Leaders As Pipeline And Portfolio Expand - Yahoo FinanceYahoo Finance · Sat, 01 Aug 2026 07:00:00 GMTRBC Lifts Price Target on Neurocrine Biosciences to $198 From $195, Keeps Outperform Rating - Yahoo FinanceYahoo Finance · Fri, 31 Jul 2026 07:00:00 GMTNeurocrine (NBIX) Reports Q2 Earnings: What Key Metrics Have to Say - Yahoo FinanceYahoo Finance · Thu, 30 Jul 2026 07:00:00 GMTNeurocrine Biosciences, Inc. Q2 2026 Earnings Call Summary - Yahoo FinanceYahoo Finance · Thu, 30 Jul 2026 07:00:00 GMTNeurocrine Biosciences Inc (NBIX) (Q2 2026) Earnings Call Highlights: Record Revenue and Raised ... - Yahoo FinanceYahoo Finance · Thu, 30 Jul 2026 07:00:00 GMT